|
n = 40
|
|
Age, median (range)
|
30.5 years (19–85 years)
|
|
Gender
|
|
Male
|
21
|
|
Female
|
19
|
|
B symptoms
|
|
Positive
|
24
|
|
Negative
|
16
|
|
LDH
|
|
Normal
|
4
|
|
Elevated
|
36
|
|
ESR
|
|
Normal
|
0
|
|
Elevated
|
40
|
|
Ann Arbor stage
|
|
I
|
8
|
|
II
|
18
|
|
III
|
6
|
|
IV
|
8
|
|
Histology
|
|
Nodular sclerosis
|
24
|
|
Mixed cellularity
|
16
|
|
Target lesions
|
|
LNs
|
75
|
|
Other lesions
|
17
|
|
Splenic lesions
|
10
|
|
Bone lesions
|
8
|
|
RECIL response to CTH
|
|
Complete response
|
26
|
|
Partial response*
|
8
|
|
Minor response**
|
4
|
|
Stable disease
|
0
|
|
Progressive disease
|
2
|
- *Partial Response means 30% or more reduction of the summation of longest dimensions of the target lesions but not a complete response with Positive FDG-PET findings
- **Minor Response means between 10 and 30% reduction of the summation of longest dimensions of the target lesions with FDG-PET findings
